<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01768039</url>
  </required_header>
  <id_info>
    <org_study_id>MS-1191</org_study_id>
    <nct_id>NCT01768039</nct_id>
  </id_info>
  <brief_title>Vitamine D in Multiple Sclerosis</brief_title>
  <acronym>MSVit</acronym>
  <official_title>Randomised Double Blind Placebo-controlled Trial of Vitamine D Supplement in Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mazandaran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mazandaran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two hundred and forty patients with multiple sclerosis who met the study criteria will be
      enrolled in this randomized double blind placebo-controlled clinical trial.

      They will randomly assigned to placebo or vitamin D treatment group. The total time of study
      is 52 weeks and the vitamin D group will be treated by weekly 50000 International unit(IU)
      vitamin D, while the other group will receive weekly placebo. The annual relapse rate and
      EDSS will be compared at baseline, month 6 and 12.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Expanded disability state scale score (EDSS)</measure>
    <time_frame>Changes in EDSS from baseline to 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Annual relapse rate(ARR)</measure>
    <time_frame>Changes in ARR from baseline to 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treatment with weekly 50000IU vitamin D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Treatment with placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <arm_group_label>Vitamin D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI:18-30kg/m2

          -  caucasian race

          -  Relapsing remitting multiple sclerosis

          -  treatment with interferon beta

        Exclusion Criteria:

          -  Recent vitamin D supplement therapy

          -  Restricted fat diet

          -  nephrolithiasis in recent 5 years

          -  Past history of hyperparathyroidism, sarcoidosis, cancer

          -  Past history of hepatic disease

          -  Past history of gastrointestinal disease

          -  Past history of mycobacterial infection

          -  Past history of hypercalcemia and hypercalciuria

          -  serum creatinine&gt;1.5

          -  Smoking, drug abuse and corticosteroid therapy in recent year

          -  treatment with thiazides or other drugs that inhibit vitamin D absorption

          -  Disease attack in recent 2 months

          -  Serum Ca&gt;2.6mm0l/L

          -  Serum 25(OH)D&gt;85mmol/L

          -  hypersensitivity to cholecalciferol

          -  Past history of heart disease

          -  Major depression

          -  Uncontrolled hypertension (BP&gt;180/110)

          -  Immunosuppressive therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mahmoud Abedini, MD</last_name>
    <phone>01513243158</phone>
    <email>mahmoudabedini@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mazandaran University of medical sciences</name>
      <address>
        <city>Sari</city>
        <state>Mazandaran</state>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Mahmoud Abedini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 11, 2013</study_first_submitted>
  <study_first_submitted_qc>January 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2013</study_first_posted>
  <last_update_submitted>January 11, 2013</last_update_submitted>
  <last_update_submitted_qc>January 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mazandaran University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Mahmoud Abedini</investigator_full_name>
    <investigator_title>associate professor of neurology</investigator_title>
  </responsible_party>
  <keyword>Multiple sclerosis</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>EDSS</keyword>
  <keyword>ARR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

